Literature DB >> 3822867

Right atrial thrombosis: rare complication of the modified Fontan procedure.

F L Shannon, D N Campbell, D R Clarke.   

Abstract

A four-year-old boy with DORV and hypoplastic left ventricle underwent a modified Fontan procedure. He had a very difficult postoperative course complicated by continued pleural effusions. Eventually he died during a last ditch effort to ligate the thoracic duct at the right diaphragm. At autopsy, an obstructing giant thrombus was found in the right atrium. This rare complication probably was due to multiple factors, but we now anticoagulate all Fontan patients routinely in an effort to prevent this fatal problem.

Entities:  

Mesh:

Year:  1986        PMID: 3822867     DOI: 10.1007/BF02093182

Source DB:  PubMed          Journal:  Pediatr Cardiol        ISSN: 0172-0643            Impact factor:   1.655


  8 in total

1.  An operation for the correction of tricuspid atresia.

Authors:  G Kreutzer; E Galíndez; H Bono; C De Palma; J P Laura
Journal:  J Thorac Cardiovasc Surg       Date:  1973-10       Impact factor: 5.209

2.  Experience with the Fontan procedure.

Authors:  H Laks; J C Milliken; J K Perloff; W E Hellenbrand; B L George; A Chin; T G Di Sessa; R G Williams
Journal:  J Thorac Cardiovasc Surg       Date:  1984-12       Impact factor: 5.209

3.  Repair of tricuspid atresia in 100 patients.

Authors:  F Fontan; C Deville; J Quaegebeur; J Ottenkamp; N Sourdille; A Choussat; G A Brom
Journal:  J Thorac Cardiovasc Surg       Date:  1983-05       Impact factor: 5.209

4.  Pulmonary artery thrombosis associated with anomalous pulmonary venous connection: an unusual complication following the modified Fontan procedure.

Authors:  T P Downing; G K Danielson; D G Ritter; P R Julsrud; J B Seward
Journal:  J Thorac Cardiovasc Surg       Date:  1985-09       Impact factor: 5.209

5.  Modified Fontan operation for univentricular heart and complicated congenital lesions.

Authors:  A W Gale; G K Danielson; D C McGoon; D D Mair
Journal:  J Thorac Cardiovasc Surg       Date:  1979-12       Impact factor: 5.209

6.  The Fontan procedure in the absence of the interatrial septum. Failure of its principle?

Authors:  D Di Carlo; C Marcelletti; A Nijveld; L J Lubbers; A E Becker
Journal:  J Thorac Cardiovasc Surg       Date:  1983-06       Impact factor: 5.209

7.  Surgical management of occluded conduits after the Fontan operation in patients with Glenn shunts.

Authors:  S Y DeLeon; R Koopot; D D Mair; F S Idriss; M N Ilbawi; A J Muster; M H Paul
Journal:  J Thorac Cardiovasc Surg       Date:  1984-10       Impact factor: 5.209

8.  Experimental evaluation of atrial function in right atrium--pulmonary artery conduit operation for tricuspid atresia.

Authors:  H Matsuda; Y Kawashima; H Takano; K Miyamoto; T Mori
Journal:  J Thorac Cardiovasc Surg       Date:  1981-05       Impact factor: 5.209

  8 in total
  5 in total

Review 1.  Thromboembolism and the role of anticoagulation in the Fontan patient.

Authors:  M L Jacobs; K K Pourmoghadam
Journal:  Pediatr Cardiol       Date:  2007 Nov-Dec       Impact factor: 1.655

2.  Right heart thrombus in infants and children.

Authors:  K Kádár; I Hartyánszky; L Király; L Bendig
Journal:  Pediatr Cardiol       Date:  1991-01       Impact factor: 1.655

3.  Anticoagulation and incidence of late cerebrovascular accidents following the Fontan procedure.

Authors:  C B Mahnke; G J Boyle; J E Janosky; R D Siewers; F A Pigula
Journal:  Pediatr Cardiol       Date:  2005 Jan-Feb       Impact factor: 1.655

4.  MDCT evaluation of pulmonary embolism in children and young adults following a lateral tunnel Fontan procedure: optimizing contrast-enhancement techniques.

Authors:  Sanjay P Prabhu; Soran Mahmood; Laureen Sena; Edward Y Lee
Journal:  Pediatr Radiol       Date:  2009-05-27

5.  Investigation of Atrial Vortices Using a Novel Right Heart Model and Possible Implications for Atrial Thrombus Formation.

Authors:  Utku Gülan; Ardan Saguner; Deniz Akdis; Alexander Gotschy; Robert Manka; Corinna Brunckhorst; Markus Holzner; Firat Duru
Journal:  Sci Rep       Date:  2017-12-01       Impact factor: 4.379

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.